Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

CD19-redirected chimeric antigen receptor (CAR) T cells have shown remarkable activity against B-cell cancers. While second-generation CARs induce complete remission in >80% of patients with acute lymphoblastic leukemia, similar monotherapy induces long-term remissions in only 26% of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, McKensie A., Jung, In-Young, Zhao, Ziran, Apodaca, Kimberly, Kong, Weimin, Lundh, Stefan, Fraietta, Joseph A., Kater, Arnon P., Sun, Clare, Wiestner, Adrian, Melenhorst, J. Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010331/
https://www.ncbi.nlm.nih.gov/pubmed/36922932
http://dx.doi.org/10.1158/2767-9764.CRC-22-0200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010331/
https://www.ncbi.nlm.nih.gov/pubmed/36922932
http://dx.doi.org/10.1158/2767-9764.CRC-22-0200

Ejemplares similares